GL1X · GenesisL1 explorer

MolNFT v1 · #105984 · protein

Crystal structure of Z. mays CK2ALPHA in complex with the ATP- competitive inhibitor 4-[(E)-(fluoren-9-ylidenehydrazinylidene)- methyl] benzoate

4RLK · Casein kinase II subunit alpha: “Crystal structure of Z. mays CK2ALPHA in complex with the ATP- competitive inhibitor…”. X-ray diffraction, 1 ligand (E91), 2 pockets (best druggability 0.72). MolNFT v1 #105984 on GenesisL1: 3D…

PDB
4RLK
Type
protein
Length
327 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Casein kinase II subunit alpha
EC
2.7.11.1
UniProt
P28523
Ligands
E91
Pockets
2 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACasein kinase II subunit alpha (EC 2.7.11.1)protein32746% helix, 16% strandP28523

Ligands and binding sites

  • E91 · 4-[(E)-(9H-fluoren-9-ylidenehydrazinylidene)methyl]benzoic acid · ligand · chains A
  • GOL · Glycerol · additive · 3 copies · chains A
  • ACT · Acetate ion · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13920.720.8348GOL, E91
2570.310.7612empty

Compared structures

  • 4RLK · Crystal structure of Z. mays CK2alpha in complex with the ATP-competitive inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00
  • P28523 · AlphaFold monomer V2.0 prediction for casein kinase II subunit alpha (P28523) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.